Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  55 results for ""MORTALITY""

Your Filters

Publication : american journal of clinical dermatology Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Association of Early Systemic Corticosteroid Therapy with Mortality in Patients with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis: A Retrospective Cohort Study Using a Nationwide Claims Database.

  • Authors : Morita K; Department of Clinical Epidemiology and Health Economics, School of Public Health, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. .; Matsui H

Subjects: Glucocorticoids/Glucocorticoids/Glucocorticoids/*therapeutic use ; Stevens-Johnson Syndrome/Stevens-Johnson Syndrome/Stevens-Johnson Syndrome/*mortality; Adult

  • Source: American journal of clinical dermatology [Am J Clin Dermatol] 2019 Aug; Vol. 20 (4), pp. 579-592.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events.

  • Authors : Yoon DJ; Department of Dermatology, University of California Davis School of Medicine, Institute for Regenerative Cures, 2921 Stockton Blvd, Ste 1630, Sacramento, CA, 95817, USA.; Dermatology Service, VA Northern California Health Care System, Mather, CA, USA.

Subjects: Adrenergic beta-Antagonists/Adrenergic beta-Antagonists/Adrenergic beta-Antagonists/*adverse effects ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*chemically induced ; Drug Repositioning/Drug Repositioning/Drug Repositioning/*history

  • Source: American journal of clinical dermatology [Am J Clin Dermatol] 2021 Jan; Vol. 22 (1), pp. 89-99. Date of Electronic Publication: 2020 Nov 25.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis.

Subjects: ONLINE information services; MEDICAL databases; LENGTH of stay in hospitals

  • Source: American Journal of Clinical Dermatology; Jul2023, Vol. 24 Issue 4, p637-647, 11p

Record details

Read More Add to Saved list
×
Academic Journal

Impact of Circulating and Tissue Biomarkers in Adjuvant and Neoadjuvant Therapy for High-Risk Melanoma: Ready for Prime Time?

  • Authors : Indini A; Medical Oncology Unit, Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Roila F

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*analysis ; Melanoma/Melanoma/Melanoma/*therapy ; Neoadjuvant Therapy/Neoadjuvant Therapy/Neoadjuvant Therapy/*methods

  • Source: American journal of clinical dermatology [Am J Clin Dermatol] 2021 Jul; Vol. 22 (4), pp. 511-522. Date of Electronic Publication: 2021 May 25.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization and Mortality in Patients with Psoriasis: A Population-Based Study.

Subjects: MORTALITY risk factors; CHRONIC kidney failure complications; PSORIASISISRAEL

  • Source: American Journal of Clinical Dermatology; Sep2021, Vol. 22 Issue 5, p709-718, 10p

Record details

Read More Add to Saved list
×
Academic Journal

Mechanisms of Resistance to BRAF-Targeted Melanoma Therapies.

  • Authors : Dulgar O; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.; Kutuk T

Subjects: Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/drug effects ; Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/genetics ; Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/immunology

  • Source: American journal of clinical dermatology [Am J Clin Dermatol] 2021 Jan; Vol. 22 (1), pp. 1-10.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

An Update on the Role of Talimogene Laherparepvec (T-VEC) in the Treatment of Melanoma: Best Practices and Future Directions.

  • Authors : Larocca CA; Department of Dermatology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, MA, USA.; LeBoeuf NR

Subjects: Practice Guidelines as Topic*; Biological Products/Biological Products/Biological Products/*administration & dosage ; Immunotherapy/Immunotherapy/Immunotherapy/*standards

  • Source: American journal of clinical dermatology [Am J Clin Dermatol] 2020 Dec; Vol. 21 (6), pp. 821-832.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Long-Term Outcomes in BRAF-Mutated Melanoma Treated with Combined Targeted Therapy or Immune Checkpoint Blockade: Are We Approaching a True Cure?

  • Authors : Schummer P; Department of Dermatology, University Hospital Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Germany.; Schilling B

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/*therapeutic use ; Melanoma/Melanoma/Melanoma/*drug therapy

  • Source: American journal of clinical dermatology [Am J Clin Dermatol] 2020 Aug; Vol. 21 (4), pp. 493-504.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

When is it OK to Stop Anti-Programmed Death 1 Receptor (PD-1) Therapy in Metastatic Melanoma?

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage ; Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/*prevention & control ; Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/*administration & dosage

  • Source: American journal of clinical dermatology [Am J Clin Dermatol] 2020 Jun; Vol. 21 (3), pp. 313-321.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients.

  • Authors : Wohlmuth C; Division of Gynecologic Oncology, Department of Surgical Oncology, University Health Network, Toronto, ON, Canada. .; Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada. .

Subjects: Melanoma/Melanoma/Melanoma/*mortality ; Vaginal Neoplasms/Vaginal Neoplasms/Vaginal Neoplasms/*mortality ; Vulvar Neoplasms/Vulvar Neoplasms/Vulvar Neoplasms/*mortality

  • Source: American journal of clinical dermatology [Am J Clin Dermatol] 2020 Apr; Vol. 21 (2), pp. 285-295.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  55 results for ""MORTALITY""